Selective labelling of ICC, PDGFRα+ cells and SMCs was achieved using antibodies for c-Kit, PDGFRα and smMHC, respectively, while GCaMP6f+ cells were labelled with an antibody for GFP. This evidence concerns the gene KIT and intrahepatic cholangiocarcinoma.